References
- Wikland M, Nygren KG. Var femte behandling botar barnlöshet. Läkartidningen 1994; 91: 520–1
- Phelps C E, Mushlin AI. On the (near) equivalence of cost-effectiveness and cost-benefit analyses. Int J Technol Assess Health Care 1991; 7: 12–21
- Eastaugh SR. Valuation of the benefits of risk-free blood. Willingness to pay for hemoglobin solutions. Int J Technol Assess Health Care 1991; 7: 51–7
- Sugden R, Williams A. The principles of practical cost-benefit analysis. Oxford University Press. 1978
- Johannesson M, Jönsson B. Economic evaluation in health care: Is there a role for cost-benefit analysis. Health Policy 1991; 17: 1–23
- Johannesson M, Jönsson B. Willingness to pay for antihypertensive therapy-results of a Swedish pilot study. J Health Econom 1991; 10: 461–74
- Johannesson M. Economic evaluation of hypertension treatment. Int J Technol Assess Health Care 1992; 8: 506–23
- Haan G. Effects and costs of in vitro fertilization, again let's be honest. Int J Technol Assess Health Care 1991; 7: 585–93
- Wikland M, Nygren K-G. Nytt rapporteringssystem skall ge bättre utvärdering av provrörsbefruktning. Läkartidningen 1992; 89: 2348–9
- Mazure C M, Greenfeld DA. Psychological studies of in vitro fertilization/embryo transfer participants. J in vitro. Fert Embryo Transf 1989; 4: 242–56
- Tan S-L, Balen A, Hussein EE. A prospective randomized study of the optimum timing of human chorionic gonadotropin adminstration after pituitary desensitization in in vitro fertilization. Fertil Steril 1992; 57: 1259–64
- Seoud MA-F, Toner J P, Kruithoff C, Muasher SJ. Outcome of twin, triplet and quadruplet in vitro fertilization pregnancies: the Norfolk experience. Fertil Steril 1992; 57: 825–34
- Lindberg B, Kjellmer I, Wennergren M, Rydhstrom H. Flerbörd ett ökande obstetriskt och pediatriskt problem. Läkartidningen 1994; 91: 806–11